BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 23945586)

  • 1. RNAi screens in mice identify physiological regulators of oncogenic growth.
    Beronja S; Janki P; Heller E; Lien WH; Keyes BE; Oshimori N; Fuchs E
    Nature; 2013 Sep; 501(7466):185-90. PubMed ID: 23945586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activating FGFR3 mutations cause mild hyperplasia in human skin, but are insufficient to drive benign or malignant skin tumors.
    Duperret EK; Oh SJ; McNeal A; Prouty SM; Ridky TW
    Cell Cycle; 2014; 13(10):1551-9. PubMed ID: 24626198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translation from unconventional 5' start sites drives tumour initiation.
    Sendoel A; Dunn JG; Rodriguez EH; Naik S; Gomez NC; Hurwitz B; Levorse J; Dill BD; Schramek D; Molina H; Weissman JS; Fuchs E
    Nature; 2017 Jan; 541(7638):494-499. PubMed ID: 28077873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mouse models: Novel in vivo RNAi screen in mice.
    Lokody I
    Nat Rev Cancer; 2013 Oct; 13(10):682. PubMed ID: 24030505
    [No Abstract]   [Full Text] [Related]  

  • 5. NF-kappaB blockade and oncogenic Ras trigger invasive human epidermal neoplasia.
    Dajee M; Lazarov M; Zhang JY; Cai T; Green CL; Russell AJ; Marinkovich MP; Tao S; Lin Q; Kubo Y; Khavari PA
    Nature; 2003 Feb; 421(6923):639-43. PubMed ID: 12571598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric oxide production upregulates Wnt/β-catenin signaling by inhibiting Dickkopf-1.
    Du Q; Zhang X; Liu Q; Zhang X; Bartels CE; Geller DA
    Cancer Res; 2013 Nov; 73(21):6526-37. PubMed ID: 24008318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of splicing factor-1 in beta-catenin/T-cell factor-4-mediated gene transactivation and pre-mRNA splicing.
    Shitashige M; Naishiro Y; Idogawa M; Honda K; Ono M; Hirohashi S; Yamada T
    Gastroenterology; 2007 Mar; 132(3):1039-54. PubMed ID: 17383426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal ROCK2 induces AKT1/GSK3β/β-catenin, NFκB and dermal tenascin C; but enhanced differentiation and p53/p21 inhibit papilloma.
    Masre SF; Rath N; Olson MF; Greenhalgh DA
    Carcinogenesis; 2020 Oct; 41(10):1409-1420. PubMed ID: 31907522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pak1 maintains epidermal stem cells by regulating Langerhans cells and is required for skin carcinogenesis.
    Okumura K; Saito M; Yoshizawa Y; Ito Y; Isogai E; Araki K; Wakabayashi Y
    Oncogene; 2020 Jun; 39(24):4756-4769. PubMed ID: 32427988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of beta-catenin in epidermal stem cell expansion, lineage selection, and cancer.
    Watt FM; Collins CA
    Cold Spring Harb Symp Quant Biol; 2008; 73():503-12. PubMed ID: 19022747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TTPAL Promotes Colorectal Tumorigenesis by Stabilizing TRIP6 to Activate Wnt/β-Catenin Signaling.
    Gou H; Liang JQ; Zhang L; Chen H; Zhang Y; Li R; Wang X; Ji J; Tong JH; To KF; Sung JJY; Chan FKL; Fang JY; Yu J
    Cancer Res; 2019 Jul; 79(13):3332-3346. PubMed ID: 31018940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional Regulation of Wnt/β-Catenin Pathway in Colorectal Cancer.
    Bian J; Dannappel M; Wan C; Firestein R
    Cells; 2020 Sep; 9(9):. PubMed ID: 32961708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MENA is a transcriptional target of the Wnt/beta-catenin pathway.
    Najafov A; Seker T; Even I; Hoxhaj G; Selvi O; Ozel DE; Koman A; Birgül-İyison N
    PLoS One; 2012; 7(5):e37013. PubMed ID: 22615875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Axin inhibits extracellular signal-regulated kinase pathway by Ras degradation via beta-catenin.
    Jeon SH; Yoon JY; Park YN; Jeong WJ; Kim S; Jho EH; Surh YJ; Choi KY
    J Biol Chem; 2007 May; 282(19):14482-92. PubMed ID: 17374607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pin1 inhibition potently suppresses gastric cancer growth and blocks PI3K/AKT and Wnt/β-catenin oncogenic pathways.
    Zhang Z; Yu W; Zheng M; Liao X; Wang J; Yang D; Lu W; Wang L; Zhang S; Liu H; Zhou XZ; Lu KP
    Mol Carcinog; 2019 Aug; 58(8):1450-1464. PubMed ID: 31026381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human telomerase reverse transcriptase (hTERT) is a novel target of the Wnt/β-catenin pathway in human cancer.
    Zhang Y; Toh L; Lau P; Wang X
    J Biol Chem; 2012 Sep; 287(39):32494-511. PubMed ID: 22854964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CREPT facilitates colorectal cancer growth through inducing Wnt/β-catenin pathway by enhancing p300-mediated β-catenin acetylation.
    Zhang Y; Wang S; Kang W; Liu C; Dong Y; Ren F; Wang Y; Zhang J; Wang G; To KF; Zhang X; Sung JJ; Chang Z; Yu J
    Oncogene; 2018 Jun; 37(26):3485-3500. PubMed ID: 29563608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-302b inhibits tumorigenesis by targeting EphA2 via Wnt/ β-catenin/EMT signaling cascade in gastric cancer.
    Huang J; He Y; Mcleod HL; Xie Y; Xiao D; Hu H; Chen P; Shen L; Zeng S; Yin X; Ge J; Li L; Tang L; Ma J; Chen Z
    BMC Cancer; 2017 Dec; 17(1):886. PubMed ID: 29273006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UHRF2 promotes intestinal tumorigenesis through stabilization of TCF4 mediated Wnt/β-catenin signaling.
    Li L; Duan Q; Zeng Z; Zhao J; Lu J; Sun J; Zhang J; Siwko S; Wong J; Shi T; Zhang X; Liu M; Chen J; Li D
    Int J Cancer; 2020 Oct; 147(8):2239-2252. PubMed ID: 32372448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological techniques: An embryonic view of tumour development.
    Schweiger PJ; Jensen KB
    Nature; 2013 Sep; 501(7466):171-2. PubMed ID: 23945591
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.